Fast-tracked: FDA to give priority review for Narcan over-the-counter nasal spray

The Wall Street Journal is reporting today that the FDA is fast-tracking approval of an over-the-counter Narcan nasal spray. The FDA has made a push to encourage pharmaceutical companies to apply for approval of over-the-counter opioid-reversal nasal spray because of the fentanyl crisis ravaging communities across America.Read More